{{Rsnum
|rsid=4792847
|Gene=MAP3K14
|Chromosome=17
|position=45306118
|Orientation=plus
|GMAF=0.3802
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MAP3K14
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 14.1 | 45.3 | 40.6
| HCB | 73.3 | 24.4 | 2.2
| JPT | 86.4 | 13.6 | 0.0
| YRI | 33.3 | 41.3 | 25.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 73.3 | 24.4 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19262425
|Title=Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}